Assertio (ASRT) Projected to Post Earnings on Monday

Assertio (NASDAQ:ASRT) is expected to issue its Q1 2025 quarterly earnings data before the market opens on Monday, May 5th. Analysts expect Assertio to post earnings of ($0.03) per share and revenue of $27.52 million for the quarter.

Assertio Price Performance

Assertio stock opened at $0.65 on Friday. The business’s 50 day simple moving average is $0.68 and its 200 day simple moving average is $0.83. Assertio has a 12 month low of $0.51 and a 12 month high of $1.80. The company has a market cap of $62.22 million, a price-to-earnings ratio of -0.89, a PEG ratio of 3.25 and a beta of 0.56. The company has a current ratio of 2.01, a quick ratio of 1.57 and a debt-to-equity ratio of 0.30.

Analyst Upgrades and Downgrades

Several research firms recently commented on ASRT. HC Wainwright cut their price objective on shares of Assertio from $4.00 to $3.50 and set a “buy” rating for the company in a report on Wednesday, March 19th. StockNews.com upgraded Assertio from a “hold” rating to a “buy” rating in a research note on Monday, April 14th. Finally, Industrial Alliance Securities set a $1.75 price objective on shares of Assertio in a research note on Friday, March 14th.

Assertio Company Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.